Lawrence Olanoff
Vorsitzender bei Ariel Pharmaceuticals, Inc.
Profil
Lawrence S.
Olanoff is currently the Chairman at Ariel Pharmaceuticals, Inc., Clinical Biotechnology Research Institute, Mitochondria.
In Motion, Inc., Elliot & Eleanor Foundation, MUSC Foundation for Research Development, Zucker Institute For Applied Neurosciences, Tevard Biosciences, Inc., Tac Development Ltd., and Ichnos Sciences, Inc. He is also the Chief Operating Officer at Almirall Ltd.
and an Advisor at Good Growth Capital Management LLC.
In the past, Dr. Olanoff served as the President, Chief Executive Officer & Director at Imunon, Inc. from 2005 to 2006.
He was also the Chairman of the Clinical Biotechnology Research Institute at Roper St. Francis Hospital.
From 1995 to 2014, he worked as a Director at Forest Laboratories, Inc. He served as an Independent Director at Ironwood Pharmaceuticals, Inc. from 2015 to 2022 and as an Independent Non-Executive Director at Sio Gene Therapies, Inc. from 2015 to 2017.
Additionally, he held positions at The Upjohn Co., Sandoz Pharmaceuticals Corp., and Medical University of South Carolina Foundation.
Dr. Olanoff obtained a doctorate degree from Case Western Reserve University in 1981.
He also holds a graduate degree from Rutgers State University of New Jersey, conferred in 1975, and an undergraduate degree from Tufts University.
Aktive Positionen von Lawrence Olanoff
| Unternehmen | Position | Beginn |
|---|---|---|
Almirall Ltd.
 Almirall Ltd. Pharmaceuticals: OtherHealth Technology Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease. | Geschäftsführer | 27.01.2011 |
| MUSC Foundation for Research Development | Direktor/Vorstandsmitglied | - |
Ariel Pharmaceuticals, Inc.
 Ariel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ariel Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Broomfield, CO. The company was founded by Steve A. Orndorff. | Vorsitzender | - |
| Clinical Biotechnology Research Institute | Vorsitzender | - |
| Zucker Institute For Applied Neurosciences | Direktor/Vorstandsmitglied | - |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Direktor/Vorstandsmitglied | 22.09.2020 |
| Mitochondria In Motion, Inc. | Vorsitzender | - |
| Tac Development Ltd. | Direktor/Vorstandsmitglied | - |
| Elliot & Eleanor Foundation | Vorsitzender | - |
| ░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ | - |
Ehemalige bekannte Positionen von Lawrence Olanoff
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Lawrence Olanoff
| Case Western Reserve University | Doctorate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Tufts University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 17 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| The Upjohn Co. | Health Technology |
| MUSC Foundation for Research Development | |
| Sandoz Pharmaceuticals Corp. | |
Medical University of South Carolina Foundation
 Medical University of South Carolina Foundation Investment Trusts/Mutual FundsMiscellaneous Medical University of South Carolina Foundation engages in the provision of educational foundation. It supports the education, research, patient care, and other programs at the Medical University. The company was founded in 1966 and is headquartered in Charleston, SC. | Miscellaneous |
Almirall Ltd.
Almirall Ltd. Pharmaceuticals: OtherHealth Technology Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease. | Health Technology |
Ariel Pharmaceuticals, Inc.
Ariel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ariel Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Broomfield, CO. The company was founded by Steve A. Orndorff. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Clinical Biotechnology Research Institute | |
Roper St. Francis Hospital
 Roper St. Francis Hospital Hospital/Nursing ManagementHealth Services Roper St. Francis Hospital is a not-for-profit health system based in Charleston, SC. The hospital provides emergency care services with 24-hour emergency rooms in Charleston and Dorchester counties. The hospital is the preferred healthcare provider in the Lowcountry, with many families choosing them for their healthcare needs. | Health Services |
Good Growth Capital Management LLC
 Good Growth Capital Management LLC Investment ManagersFinance Good Growth Capital Management LLC (Good Growth Capital) is a venture capital subsidiary of Capital A Partners LLC founded in 2017 by Amy Salzhauer and Maureen Stancik Boyce. The firm is headquartered in Charleston, South Carolina. | Finance |
| Zucker Institute For Applied Neurosciences | |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Commercial Services |
| Tac Development Ltd. | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Commercial Services |
| Mitochondria In Motion, Inc. | |
| Elliot & Eleanor Foundation |
